Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)
Clinical trial NCT07770815 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07770815
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2029-12-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.